Janssen sends off NDA for new multiple sclerosis drug ponesimod

Johnson & Johnson has handed in its NDA for its multiple sclerosis hopeful as it hopes to get in on this blockbuster market.

Janssen sends off NDA for new multiple sclerosis drug ponesimod
Johnson & Johnson has handed in its NDA for its multiple sclerosis hopeful as it hopes to get in on this blockbuster market.